ArticleFrontiers in immunology2023

Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle.

Jonas Steenbrugge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.